TIAA CREF INVESTMENT MANAGEMENT LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$8,198,000
+12.7%
217,807
+2.7%
0.01%0.0%
Q4 2018$7,275,000
-66.8%
211,988
-54.6%
0.01%
-14.3%
Q3 2018$21,930,000
+169.3%
466,584
+93.3%
0.01%
+40.0%
Q2 2018$8,142,000
+21.7%
241,395
-2.4%
0.01%0.0%
Q1 2018$6,691,000
+217.3%
247,256
+95.6%
0.01%
+400.0%
Q4 2017$2,109,000
+4.0%
126,440
+24.8%
0.00%0.0%
Q3 2017$2,028,000
+21.7%
101,329
+11.4%
0.00%0.0%
Q2 2017$1,667,000
+75.8%
90,956
-5.6%
0.00%0.0%
Q1 2017$948,000
-7.1%
96,318
+3.0%
0.00%0.0%
Q4 2016$1,021,000
-31.8%
93,544
-12.4%
0.00%0.0%
Q3 2016$1,496,000
+62.1%
106,802
-18.7%
0.00%0.0%
Q2 2016$923,000
+31.1%
131,424
+20.3%
0.00%0.0%
Q1 2016$704,000
-83.5%
109,257
-16.9%
0.00%
-66.7%
Q4 2015$4,257,000
+17.5%
131,401
-3.2%
0.00%0.0%
Q3 2015$3,623,000
-45.8%
135,700
-2.4%
0.00%
-40.0%
Q2 2015$6,690,000
+13.0%
138,998
+42.8%
0.01%
+25.0%
Q1 2015$5,922,000
+19.4%
97,324
+1.6%
0.00%
+33.3%
Q4 2014$4,960,000
+14.5%
95,802
-2.7%
0.00%0.0%
Q3 2014$4,331,000
+66.2%
98,418
-1.3%
0.00%
+50.0%
Q2 2014$2,606,000
+149.9%
99,686
+149.7%
0.00%
+100.0%
Q1 2014$1,043,000
+126.2%
39,918
+46.8%
0.00%
Q4 2013$461,000
-9.4%
27,188
+14.5%
0.00%
Q3 2013$509,00023,7380.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders